A comparative study of the new xylarate germanium (IV) complexe with lithium (xygerm-1), lithium chloride and valproic acid to the amphetamine-enhanced self-stimulation reactions in rats

Abstract

Aim. To estimate the effect of novel lythium bis(µ-xylarato)dihydrogermanate (IV) (Xygerm-1) on reinforcing properties of the lateral hypothalamus self-stimulation in rats compared to the reference drugs (lithium chloride and valproic acid) in rats with amphetamine-induced self-stimulation. Methods. To form a model of the brain self-stimulation, nichrome monopolar electrodes were implanted bilaterally in the lateral hypothalamic nucleus, followed by morphological control, and 7-10 days after the operation, the rats were trained to press a pedal for electrical stimulation of the brain. The effects of self-stimulation were assessed by analyzing the maximum rate of pedal pressing and the self-stimulation threshold. Study of the test compounds effects had been started when average self-stimulation threshold values varied by less than 10% for three consecutive sessions of the brain self-stimulation. Xygerm-1 (300-1800 mg/kg), valproic acid (30-300 mg/kg) and lithium chloride (25-200 mg/kg) were introduced as intraperitoneal injections to animals of the corresponding study groups (6 rats each). At the next stage of the experiment, effects of Xygerm-1, lithium chloride and valproic acid on amphetamine-induced (dose 0.5 mg/kg) brain self-stimulation reaction increase were studied at the same animal groups. Results. At the first stage of the experiment Xygerm-1 (1200 and 1800 mg/kg), lithium chloride (100 and 200 mg/kg) and valproic acid (300 mg/kg) had significantly increased self-stimulation threshold. High doses of Xygerm-1 and lithium chloride (1800 and 200 mg/kg correspondingly) had relevantly decreased the average self-stimulation rate. There was also a tendency for the average self-stimulation rate to decrease in animals administered valproic acid, though, not statistically significant. The use of Xygerm-1 and lithium chloride induced the dose-dependant self-stimulation threshold increase, decreased by the use of amphetamine sulfate. Rather high doses of Xygerm-1 and lithium chloride (1800 and 100 mg/kg correspondingly) had also blocked amphetamine-induced increase in pedal pressing rate. Studied doses of valproic acid did not altered the amphetamine-induced brain self-stimulation reaction increase. Conclusion. The novel compound bis(µ-xylarato)dihydrogermanate (IV) has a strong influence on behavior, in particular on the brain reward systems, which is similar to the action of lithium chloride and differs from the effect of valproic acid.

Keywords

Xygerm-1 / lithium chloride / valproid acid / psychopharmacological drugs / brain self-stimulation / rats

References

[1] Варбанець О.I., Годован В.В., Кащенко О.А. Вплив нових ксиларатних комплексiв германiю (IV) на прояви синдрому стереотипно¿ поведiнки у щурiв // Одес. мед. ж. - 2012. - №4. - С. 15-18.

[2] Шабанов П.Д., Лебедев А.А., Любимов А.В. и др. Динамика реакции самостимуляции мозга у крыс после форсированного введения психоактивных веществ // Психофармакол. и биологич. наркол. - 2009. - Т. 9, вып. 1-2. - С. 2524-2529.

[3] Anand A., Verhoeff P., Seneca N. et al. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar dosoder patients // Am. J. Psychiatry. - 2000. - Vol. 157. - Р. 1108-1114.

[4] Baldessarini R.J. Treatment research in bipolar disorder: issues and recommendations // CNS Drugs. - 2002. - Vol. 16. - Р. 721-729.

[5] Belmaker R.H. Bipolar disorder // N. Engl. J. Med. - 2004. - Vol. 351. - Р. 476-486.

[6] Carlezon Jr.W.A., Chartoff E.H. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation // Nat. Protoc. - 2007. - Vol. 2. - Р. 2987-2995.

[7] Cassens G.P., Mills A.W. Lithium and amphetamine: opposite effects on threshold of intracranial reinforcement // Psychopharmacologia. - 1973. - Vol. 30. - Р. 283-290.

[8] Einat H. Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease // Behav. Genet. - 2007. - Vol. 37. - Р. 244-255.

[9] Fountoulakis K.N., Vieta E., Siamouli M. et al. Treatment of bipolar disorder: a complex treatment for a multiceted disorder // Ann. Gen. Psychiatry. - 2007. - Vol. 6. - Р. 27.

[10] Goodwin F.K., Jamison K.R. Manic-depressive illness: bipolar disorders and recurrent depression. - Oxford: Oxford university press, 2007. - 324 p.

[11] Kahn D.A., Sachs G.S., Printz D.J. et al. Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines // J. Psychiatr. Pract. - 2000. - Vol. 6. - Р. 197-211.

[12] Mavrikaki M., Nomikos G., Panagis G. Effects of mood stabilizers on brain reward processes in rats: studies using the intracranial self-stimulation paradigm // Europ. Neuropsychopharmacol. - 2009. - Vol. 19. - P. 205-214.

[13] Olds J., Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain // J. Comp. Physio. Psychol. - 1954. - Vol. 47. - P. 419-427.

[14] Paxinos G., Watson C. The rat brain in stereotaxic coordinate, sixth. - Amsterdam: Elsever, 2007. - 457 р.

[15] Slattery D.A., Markou A., Cryan J.F. Evaluation of reward processes in an animal model of depression // Psychopharmacol. - 2007. - Vol. 190. - Р. 555-568.

RIGHTS & PERMISSIONS

Varbanets E.I., Godovan V.V., Shandra A.A., Kaschenko O.A.